To The Moon

Auris Health 是一家致力於肺癌的機器人技術開發商。本次收購預計於2019年第二季度末完成，在之前，強生於去年收購了 Orthotaxy——一傢俬人控股的外科手術軟件技術開發商。 $強生(JNJ)$ $直覺外科公司(ISRG)$ #機器人# Feb 13 (Reuters) - Johnson & Johnson is buying privately held surgical robotics company Auris Health Inc for about $3.4 billion in cash, the healthcare conglomerate said on Wednesday, as it continues its push into robotics. 路透2月13日電---強生週三表示,隨着其繼續進軍機器人領域,將以約34億美元現金收購私有外科機器人公司 Auris Health Inc。 The agreement includes additional payments by J&J of $2.35 billion, contingent upon Auris reaching certain milestones, J&J said, without elaborating. 強生表示，該協議包括強生支付的23.5億美元額外款項，前提是 Auris 達到了某些里程碑。 Auris Health is a developer of robotic technologies focused on lung cancer. The deal follows J&J's acquisition last year of Orthotaxy, a privately held developer of software-enabled surgery technologies. Auris Health 是一家致力於肺癌的機器人技術開發商。在此之前，強生（J&J）於去年收購了 Orthotaxy，一家擁有軟件功能的外科技術的私營開發商。 "This acquisition will accelerate Johnson & Johnson's entry into robotics with potential for growth and expansion into other interventional applications," J&J said in a statement. 強生公司在一份聲明中說：“此次收購將加速強生公司進入機器人領域，並有可能在其他介入應用領域實現增長和擴張。” The acquisition is expected to close by the end of the second quarter of 2019. 本次收購預計於2019年第二季度末完成。